508869

- 45th Annual General Meeting (AGM) of Apollo Hospitals Enterprise Limited held on August 25, 2026. - All 8 proposed resolutions passed by shareholders, including adoption of FY26 financials, dividend confirmation, director re-appointments (including Executive Chairman), and approval to raise up to ₹7,500 million via NCDs.

- The 45th Annual General Meeting (AGM) of Apollo Hospitals Enterprise Limited was held on August 25, 2026, via video conferencing. - All 8 resolutions proposed at the AGM were passed by the shareholders with overwhelming majority. - Key resolutions passed include the adoption of financial statements for the year ended March 31, 2026, and the confirmation of interim dividend and declaration of final dividend for the same financial year. - Re-appointments of Smt. Sangita Reddy as Director, Dr. Prathap C Reddy as Director and Executive Chairman, and Smt. Rama Bijapurkar as Independent Director were approved. - Shareholders also approved raising funds up to ₹7,500 million through secured/unsecured redeemable non-convertible debentures on a private placement basis.

- The 45th Annual General Meeting (AGM) of Apollo Hospitals Enterprise Limited was held on August 25, 2026, via video conference, with 81 members attending. - All 8 proposed resolutions were passed with the requisite majority. - Resolutions included the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. - Confirmation of interim dividend payment and declaration of a final dividend for the financial year ended March 31, 2026. - Re-appointments of Dr. Prathap C Reddy as Director and Executive Chairman, and Smt. Sangita Reddy as Director. - Approval to offer/invite subscriptions for secured/unsecured redeemable non-convertible debentures aggregating up to ₹7,500 million on a private placement basis. - The Statutory Auditors Report and Secretarial Auditors Report were reported as free from any qualifications/observations.

- Announcement of the availability of the transcript of the presentation on unaudited financial results for the three months ended June 30, 2026. This presentation was made on August 13, 2026, and the transcript is accessible on the Company's website.

- Apollo Hospitals Enterprise Limited announced the availability of the audio recording of the Analyst Call on financial results for the three months ended June 30, 2026. - The recording is accessible on the Company's website.

- Q1 FY27 Consolidated Revenue ₹7,043.5 Cr vs ₹5,821.1 Cr (▲21% YoY) - EBITDA ₹1,092 Cr vs ₹853.1 Cr (▲28% YoY) - PAT ₹580.5 Cr vs ₹433.2 Cr (▲34% YoY) - EBITDA Margin 15.5% vs 14.65% (▲85bps)

- Q1 FY27 Consolidated Revenue ₹7,043.5 Cr vs ₹5,821.1 Cr (▲21% YoY) - EBITDA ₹1,092.0 Cr vs ₹853.1 Cr (▲28% YoY) - PAT ₹580.5 Cr vs ₹433.2 Cr (▲34% YoY) - EBITDA Margin 15.5% vs 14.65% (▲85bps)

- Q1 FY27 Consolidated Revenue ₹7,043.5 Cr vs ₹5,842.1 Cr (▲20.57% YoY) - EBITDA ₹1,105.5 Cr vs ₹865.5 Cr (▲27.73% YoY) - PAT ₹610.4 Cr vs ₹441.0 Cr (▲38.41% YoY) - EBITDA Margin 15.69% vs 14.81% (▲88bps) - Board approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as Statutory Auditors for a term of five years, commencing from the conclusion of the 46th AGM in 2027. - The Board took note of the proposed transfer of undertaking by Apollo Healthco Limited (a material subsidiary) to its wholly-owned subsidiary, Apollo Consumer Products Limited, on a slump sale basis. - The Board approved the grant of additional stock options and RSUs aggregating to 46,798 equity shares to new employees under the Apollo ESOP Plan 2024.

- Q1 FY27 Consolidated Revenue ₹70,435 Mn vs ₹58,421 Mn (▲20.6% YoY) - EBITDA ₹11,055 Mn vs ₹8,655 Mn (▲27.7% YoY) - PAT ₹6,104 Mn vs ₹4,410 Mn (▲38.4% YoY) - EBITDA Margin 15.7% vs 14.8% (▲90bps)

- Q1 FY27 Consolidated Revenue ₹7,043Cr vs ₹5,842Cr (▲21% YoY) - Consolidated EBITDA ₹1,092Cr vs ₹852Cr (▲28% YoY) - Consolidated PAT ₹581Cr vs ₹433Cr (▲34% YoY) - Consolidated EBITDA Margin 15.50% vs 14.58% (▲92bps)